Trade XRTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
XORTX Therapeutics Inc. Common Shares (XRTX) is trading at US$1.95, up 1.56% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$3.71M. Over the past 52 weeks, XRTX has traded between US$1.59 and US$7.05. On Syfe you can trade XRTX with $0 commission and add it to your watchlist.
| Previous close | US$1.92 |
|---|---|
| Market cap | US$3.71M |
| 52-week range | US$1.59 – US$7.05 |
| Volume | 218.43K |
| Exchange | US |
Add to Watchlist
Set Price Alert
XORTX Therapeutics Inc. Common Shares
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.
Year: 2018
Xortx Therapeutics Appoints Mika Grasso as Co-CEO; Provides Gout Drug Update
Jun 15, 1:15 PM · MT Newswires
Stay on top of XRTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
